Related Experiment Video
Updated: May 20, 2026

A Protocol for Analyzing Hepatitis C Virus Replication
Published on: June 26, 2014
Hepatitis C virus non-structural 5B protein interacts with cyclin A2 and regulates viral propagation
Long V Pham1, Huong T T Ngo, Yun-Sook Lim
1National Research Laboratory of Hepatitis C Virus, Ilsong Institute of Life Science, Hallym University, Anyang 431-060, Republic of Korea.
Background & Aims:
Hepatitis C virus (HCV) requires host cellular proteins for its own propagation. To identify the cellular factors necessary for HCV propagation, we have recently screened the small interfering RNA (siRNA) library targeting cell cycle genes using cell culture grown HCV (HCVcc)-infected cells. In the current study, we have selected and characterized the gene encoding Cyclin A2 (CycA2). Deregulation of CycA2 has been implicated in many types of cancers, including hepatocellular carcinoma.
Methods:
The effects of CycA2 on HCV propagation were investigated by siRNA-mediated knockdown assay, in vitro and in vivo protein binding assays, luciferase reporter gene assay, and immunoblot assay.
Results:
We showed that siRNA-mediated depletion of CycA2 significantly inhibited HCV replication in both HCV subgenomic replicon cells and HCVcc-infected cells. Furthermore, HCV non-structural 5B (NS5B) specifically interacted with CycA2 in vitro and in vivo. Protein interaction was mediated through the cyclin box of CycA2 and the palm domain of NS5B. We further showed that R/HxL motif in the palm domain of HCV NS5B mediated protein interaction with CycA2 and this interaction was necessary for HCV replication. Moreover, we demonstrated that tylophorine, the natural plant product exerting a CycA2 inhibitory function, abrogated HCV replication.
Conclusions:
HCV regulates CycA2 via NS5B protein for its own propagation. In addition, tylophorine may be a potential therapeutic agent for HCV.
Insights
Hepatitis C virus (HCV) uses Cyclin A2 (CycA2) for replication, interacting via the NS5B protein. A natural compound, tylophorine, inhibits CycA2 and may treat HCV infection.
Area of Science:
- Virology
- Cell Biology
- Molecular Biology
Background:
- Hepatitis C virus (HCV) relies on host cellular proteins for replication.
- Cyclin A2 (CycA2) is a cell cycle gene implicated in cancers like hepatocellular carcinoma.
- Previous screening identified cell cycle genes crucial for HCV propagation.
Purpose of the Study:
- To investigate the role of Cyclin A2 (CycA2) in Hepatitis C virus (HCV) propagation.
- To characterize the interaction between CycA2 and HCV proteins.
- To explore potential therapeutic strategies targeting the CycA2-HCV interaction.
Main Methods:
- siRNA-mediated knockdown of CycA2 in HCV-infected cells.
- In vitro and in vivo protein binding assays to study CycA2-HCV interactions.
- Luciferase reporter gene assays and immunoblotting to assess replication and protein binding.
- Treatment with tylophorine, a CycA2 inhibitor, to evaluate its effect on HCV replication.
Main Results:
- Depletion of CycA2 significantly inhibited HCV replication.
- HCV non-structural 5B (NS5B) protein specifically interacted with CycA2.
- The interaction involved CycA2's cyclin box and NS5B's palm domain, mediated by the R/HxL motif.
- Tylophorine abrogated HCV replication by inhibiting CycA2.
Conclusions:
- HCV utilizes NS5B to regulate CycA2 for its propagation.
- The interaction between NS5B and CycA2 is essential for HCV replication.
- Tylophorine shows potential as a therapeutic agent for HCV infection.
Related Concept Videos
Hepatitis
Positive Regulator Molecules
Positive Regulator Molecules
Inhibition of Cdk Activity
Anaphase Promoting Complex
Retrovirus Life Cycles

